Cite
HARVARD Citation
Abbas, H. et al. (2022). Clinical and molecular profiling of AML patients with chromosome 7 or 7q deletions in the context of TP53 alterations and venetoclax treatment. Leukemia & lymphoma. 63 (13), pp. 3105-3116. [Online].